ResMed saw the highest growth of 120% in patent filings in October and 120% in grants in December in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 120% and grants by 93%. GlobalData’s DataBook provides a comprehensive analysis of ResMed‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

ResMed has been focused on protecting inventions in United States(US) with 120 publications in Q4 2023

The United States(US) Patent Office dominates the patent filings and grants with nearly 53% filings and 55% grants. The United States(US), European Patent Office(EPO), Japan(JP), and China(CN) patent Office are among the top ten patent offices where ResMed is filings its patents. Among the top granted patent authorities, ResMed has 55% of its grants in United States(US), 30% in European Patent Office(EPO) and 13% in Japan(JP).

Koninklijke Philips could be the strongest competitor for ResMed

For comprehensive analysis of ResMed's filings and grants, buy the databook here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.